Chlamydia Infections
21
1
1
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
9.5%
2 terminated out of 21 trials
88.9%
+2.4% vs benchmark
19%
4 trials in Phase 3/4
0%
0 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (21)
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections
Screening of Gonococcal and Chlamydial Infections in the Third Trimester
Partner Notification for Chlamydia in Primary Care
Theater in School Sex Education - a Randomized Controlled Study
Risk Assessment of Long-Haul Truck Drivers
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II
Immunopathogenesis of Chlamydia
Inflammation, Infection, and Future Cardiovascular Risk
Infection and Cardiovascular Disease
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
Lay Health Advisors for Sexually Transmitted Disease Prevention
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
Clinical Trial of Eye Prophylaxis in the Newborn
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Chlamydia and Mycoplasma in Coronary Artery Disease
Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community